8.71
Schlusskurs vom Vortag:
$9.02
Offen:
$9.1
24-Stunden-Volumen:
3.91M
Relative Volume:
0.80
Marktkapitalisierung:
$2.49B
Einnahmen:
$6.41B
Nettoeinkommen (Verlust:
$1.30B
KGV:
1.7282
EPS:
5.04
Netto-Cashflow:
$646.00M
1W Leistung:
-9.18%
1M Leistung:
-31.09%
6M Leistung:
-45.70%
1J Leistung:
-57.53%
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OGN
Organon Co
|
8.71 | 2.49B | 6.41B | 1.30B | 646.00M | 5.04 |
![]()
LLY
Lilly Eli Co
|
734.57 | 739.39B | 49.00B | 11.11B | -1.27B | 12.29 |
![]()
JNJ
Johnson Johnson
|
154.22 | 375.64B | 89.33B | 21.81B | 18.57B | 8.99 |
![]()
ABBV
Abbvie Inc
|
184.60 | 351.09B | 57.37B | 4.20B | 17.83B | 2.35 |
![]()
NVO
Novo Nordisk Adr
|
65.77 | 307.32B | 43.59B | 15.04B | 10.74B | 3.3766 |
![]()
NVS
Novartis Ag Adr
|
108.70 | 225.73B | 53.22B | 12.86B | 14.85B | 6.39 |
Organon Co Stock (OGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
2023-09-21 | Eingeleitet | Barclays | Overweight |
2023-03-16 | Eingeleitet | Raymond James | Outperform |
2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
2022-04-27 | Eingeleitet | Goldman | Buy |
2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
2021-09-01 | Eingeleitet | BofA Securities | Buy |
2021-07-22 | Eingeleitet | Citigroup | Buy |
2021-06-15 | Eingeleitet | JP Morgan | Neutral |
2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
OGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire
OGN STOCK ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of an Ongoing Investigation - ACCESS Newswire
Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ORGANON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Why Investors Shouldn't Be Surprised By Organon & Co.'s (NYSE:OGN) 30% Share Price Plunge - simplywall.st
Levi & Korsinsky Announces an Investigation on Behalf of Organon & Co. (OGN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets - marketscreener.com
Organon: Management Slashes DividendThis Feels Disastrous (NYSE:OGN) - Seeking Alpha
2025-05-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation | NYSE:OGN | Press Release - Stockhouse
Ex-Dividend Reminder: H2O America, Exelon Corp and Organon & Co - Nasdaq
EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug - marketscreener.com
Organon Executives Make Bold Moves with Major Stock Purchases - TipRanks
Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment - simplywall.st
Insider Buying: Aaron Falcione Acquires Shares of Organon & Co (OGN) - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Organon & Co. (OGN) - ACCESS Newswire
Organon & Co. Executives Increase Their Holdings - TradingView
Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - simplywall.st
Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Yahoo Finance
FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN
Levi & Korsinsky Reminds Organon & Co. Investors of the Ongoing Investigation into Potential Violations of Securities LawsOGN - ACCESS Newswire
Top Executives Make Bold Moves with Major Organon Stock Purchases! - TipRanks
Organon & Co. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsOGN - PR Newswire
Did Organon & Co. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateOGN - ACCESS Newswire
Organon downgraded to In Line from Outperform at Evercore ISI - MSN
Organon & Co. Executives Make Significant Stock Purchases - TradingView
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon & Co. (NYSE:OGN) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Organon (OGN) Faces Price Target Cut Amid Dividend Adjustment - GuruFocus
Organon & Co. (NYSE:OGN) Given New $10.00 Price Target at Morgan Stanley - Defense World
OGN Stock: Analyst Maintains Rating, Lowers Price Target to $10 | OGN Stock News - GuruFocus
Organon price target lowered to $10 from $15 at Morgan Stanley - TipRanks
OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire
Organon & Co. (NYSE:OGN) Cut to “Inline” at Evercore ISI - Defense World
Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02 - simplywall.st
Organon & Co. (NYSE:OGN) Sets New 52-Week Low – Here’s Why - Defense World
Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Brokerages Set Organon & Co. (NYSE:OGN) Target Price at $19.75 - Defense World
SLQT INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into SelectQuote, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.
OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Organon price target lowered to $10 from $11 at BofA - Yahoo Finance
Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion - MSN
Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (OGN) - Seeking Alpha
Organon & Co. SEC 10-Q Report - TradingView
Evercore ISI Downgrades Organon to In Line From Outperform - marketscreener.com
Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - Defense World
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN
Organon & Co. Earnings Call: Growth Amid Challenges - TipRanks
Organon (OGN) Faces Downgrade Following Dividend Reduction | OGN Stock News - GuruFocus
Organon Co earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia
Organon (OGN) Faces Price Target Reduction and Dividend Cut | OG - GuruFocus
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):